· 个股论点
可能尚未被定价的只有那些更小众的领域，例如在磷化铟(InP)衬底上的外延工艺，或者那些刚刚触及拐点的新型激光器/收发器玩家。 我曾提到 $IQE 处于极早期阶段（但风险更高），因为其同行 Landmark 的估值已达 35-40 亿美元。 这取决于重组情况。 $AAOI 也处于极早期，情况更微妙，因为他们提供端到端服务（激光器 -> 设计 -> 组装）。如果他们能在每一层执行到位，淘汰 $FN/中际旭创 类型的玩家并扩大利润率，可能实现 10 倍增长。 但这很大程度上取决于执行能力。 $AXTI 也许有机会，如果 Shkreli 加入董事会并教他们如何涨价的话。
Only ones probably not priced in are the more niche ones like epitaxy process on top of the InP substrates or maybe new laser/transceiver players that hit their inflection point. I mentioned $IQE was extremely early (but more high risk), given their peer Landmark was priced at $3.5-$4B. This depends on restructuring. $AAOI is also very early, it's more nuanced since they do end to end (laser -> design -> assembly). If they can execute across each layer and cut out $FN/Innolight type players and expand margins, could be a 10x. This largely depends on execution though. $AXTI maybe if Shkreli joins their board and teaches them how to hike prices.